In equities, shares of Teva Pharmaceuticals ( TEVA ) were 12% lower pre-bell after the generic drug maker reported mixed Q4 results and issued a weaker-than-expected outlook. US stocks were set for a higher open on Wednesday as recent presidential comments on the ongoing US-China trade talks drove market optimism, while investors evaluated the just released data on US inflation. President Donald Trump signaled he would allow more flexibility on the trade-deal deadline if the two sides were making enough progress.